Please Wait
Applying Filters...

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

New Haven Pharmaceuticals develops prescription drugs using well-established or GRAS (Generally Recognized as Safe) ingredients. By leveraging compounds with proven safety, the company creates innovative treatments that meet unmet medical needs. This approach reduces regulatory hurdles and accelerates time-to-market, helping patients access safe and effective therapies faster.

List your booth number for exhibitions, ask us